Tag: licensing
-
Membrane Technology to be Studied for Industrial Processes
Engineers and materials scientists at University of Minnesota in Minneapolis received funding from the U.S. Department of Energy to develop membrane technology for energy-efficient separations in a range of process industries. The three-year, $1.8 million grant from the Advanced Research Projects Agency–Energy (ARPA-E) aims to adapt lab research on nanotechnology for membranes that can improve…
-
Cancer Diagnostics Biotech Lands $13 Million Series B Funds
Epic Sciences Inc., a biotechnology diagnostics developer in San Diego, secured $13 million in series B financing, the second round of venture funding after initial start-up. The funding round includes new investors Domain Associates, Roche Venture Fund, and Pfizer Venture Investments, as well as undisclosed individual participants. Epic Sciences exclusively licensed research by the lab…
-
Genomics Institute to Back Umbilical Cord Stem Cell Company
Ontario Genomics Institute in Toronto, Canada is investing in Tissue Regeneration Therapeutics, also in Toronto, a company developing a technology for medical treatments with stems cells extracted from umbilical cords. Financial aspects of the investment were not disclosed. The technology developed by Tissue Regeneration Therapeutics uses human umbilical cord perivascular cells or HUCPVCs that are extracted…
-
Vertex to Partner with Janssen, GSK on Hepatitis C Drugs
Vertex Pharmaceuticals Inc. in Cambridge, Massachusetts will collaborate with Janssen Pharmaceuticals, a division of Johnson & Johnson, and GlaxoSmithKline (GSK) on clinical trials of Vertex’s VX-135 treatment candidate for hepatitis C. The trials will test VX-135 in combination with hepatitis C drugs made by Janssen and GSK. Financial details of the agreements were not disclosed.…
-
Pfizer Develops Equine Vaccine from University Research
The Australian division of Pfizer Animal Health in Brisbane released today a new vaccine to prevent disease from the Hendra virus that can be fatal to horses and humans. Pfizer’s Equivac HeV is the product of research conducted at Uniformed Services University of the Health Sciences (USU) and licensed from the Henry M. Jackson Foundation…
-
Cambridge Univ. Spin-Off Creates Drug Testing Stem Cells
A spin-off company from Cambridge University in the U.K. is commercializing a technology to convert adult stem cells into human liver cells suitable for drug testing. The technology, say its developers from Cambridge’s Anne McLaren Laboratory for Regenerative Medicine, can also test for a number of inherited liver diseases and has the potential to accelerate…
-
Challenge Seeks Smartphone GPS Jamming Detector
A new challenge on InnoCentive asks for a method of detecting GPS signal jamming devices using smartphones. The competiton (free registration required) has an award of $20,000 and a deadline of 3 January 2013. InnoCentive in Waltham, Massachusetts conducts open-innovation, crowd-sourcing competitions for corporate and organization sponsors. Global Positioning System (GPS) signals can be drowned…
-
Life Sciences Can Generate Start-Ups, With a Little Help
A case study of innovation in the life sciences in San Francisco shows academic researchers, with the right kind of support, can generate a high number of start-up companies producing new products for the marketplace. The study focuses on the California Institute for Quantitative Biosciences (QB3) and its entrepreneurial programs, which appears in this week’s…
-
Merck, Seiko Epson to Partner on Organic LED Inkjet Inks
The chemical company Merck in Darmstadt, Germany will license ink-jet ink technology from electronics manufacturer Seiko Epson in Tokyo for the manufacture of organic light-emitting diode (OLED) television displays. Financial terms of the agreement were not disclosed. OLEDs use thin films of carbon-based materials — thus the name “organic” — placed between two conductors. When…
-
Arcadia Biosciences to Develop Heat Tolerant Wheat
Agricultural technology company Arcadia Biosciences in Davis, California will develop heat-tolerant varieties of wheat under a $3.8 million grant from the U.S. Agency for International Development. The deal also involves the International Maize and Wheat Improvement Center (CIMMYT), which will share in the rights to the discoveries. Arcadia Biosciences says some 50 million acres of…